导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 27.82% | 41/330 |
| 近一周 | -2.08% | 162/359 |
| 近一月 | -4.36% | 290/359 |
| 近一季 | -12.28% | 262/354 |
| 近半年 | 7.73% | 193/347 |
| 近一年 | 26.85% | 51/330 |
| 近两年 | 58.25% | 26/274 |
| 近三年 | 45.12% | 76/194 |
| 成立以来 | 48.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
23.68% 23/341 |
-4.06% 321/349 |
26.87% 28/355 |
- - |
| 2024 | 24.67% 48/330 |
-2.29% 188/280 |
9.94% 22/310 |
28.22% 61/319 |
-9.49% 278/330 |
| 2023 | -9.26% 150/276 |
5.19% 73/205 |
-10.17% 201/230 |
-2.45% 35/262 |
-1.56% 169/276 |
| 2022 | -15.70% 75/202 |
-18.70% 120/153 |
13.34% 7/164 |
-20.27% 121/189 |
14.75% 53/202 |
| 2021 | -41.17% 100/151 |
-1.21% 246/312 |
-5.46% 303/328 |
-28.25% 320/358 |
-12.21% 138/151 |
| 2020 | 46.22% 6/104 |
-2.90% 47/280 |
30.84% 31/295 |
11.45% 39/299 |
3.27% 217/305 |
| 2019 | 33.48% 16/89 |
20.40% 17/258 |
-4.98% 244/268 |
-1.74% 179/253 |
18.73% 6/266 |
| 2018 | -29.38% 69/80 |
- - |
- - |
- - |
-19.34% 205/241 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇C | 0.2364 | 27.00% |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2510 | 22.82% |
| 易方达标普生物科技美元汇A | 0.2397 | 22.61% |
| 易方达标普生物科技人民币A | 1.6917 | 21.74% |
| 易方达标普生物科技人民币C | 1.6684 | 21.66% |
| 广发生物科技指数人民币(QDII)A | 1.4510 | 17.07% |
| 广发生物科技指数美元(QDII)A | 0.2056 | 14.99% |
| 广发生物科技指数美元(QDII)C | 0.2022 | 14.89% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4395 | 14.73% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3258 | 14.23% |
| 易方达中概互联50ETF VS. 天弘恒生科技指数(QDII)C(012349) |